uh. really. have you counted AND READ the last press in last just 3-4 months?! Lack of communication that's the problem. does not seem to be a problem... http://www.marketwired.com/press-release/fda-issues-ind-number-regen-biopharmas-dcellvax-therapeutic-application-proposed-treatment-otcbb-rgbp-1964157.htm http://www.marketwired.com/press-release/regen-biopharmas-chief-scientific-officer-examines-potential-role-immunotherapeutic-otcbb-rgbp-1961745.htm http://www.marketwired.com/press-release/cell-therapy-expert-dr-amit-patel-joins-regen-biopharma-inc-scientific-advisory-board-otcbb-rgbp-1957807.htm http://www.marketwired.com/press-release/regen-biopharma-inc-files-ind-application-with-fda-dcellvax-breast-cancer-immune-therapy-otcbb-rgbp-1955886.htm http://www.marketwired.com/press-release/regen-biopharma-submits-experimental-protocol-fda-hemaxellerate-aplastic-anemia-trial-otcbb-rgbp-1954889.htm http://www.marketwired.com/press-release/regen-biopharma-completes-preclinical-experiments-dcellvax-breast-cancer-immune-therapy-otcbb-rgbp-1952694.htm http://www.marketwired.com/press-release/regen-biopharma-files-patent-application-on-new-therapy-that-uses-innate-immune-system-otcbb-rgbp-1947770.htm http://www.marketwired.com/press-release/regen-biopharma-provides-update-on-hemaxellerate-ind-progress-after-conference-call-otcbb-rgbp-1945965.htm ...And the list goes on!